Norbrook Presents API and Finished Products Portfolio at CPhI

October 7, 2014
Pharmaceutical Technology Editors

Norbrook Laboratories will be showcasing its portfolio of APIs and its range of Norbrook Finished Product at CPhI Worldwide 2014.

Norbrook Laboratories will be showcasing its portfolio of APIs and its range of Norbrook Finished Product at CPhI Worldwide 2014. Norbrook’s exhibition stand is 6M99.

“Beyond Norbrook’s own-brand finished goods, we offer a range of contract manufacturing services. We offer process development from laboratory-scale, pilot-plant scale through to production-scale manufacture. We also offer a full complement of validation and technical services,” Professor James Haughey, the company’s director, said in a press release

Norbrook specializes in the manufacture of APIs, including oxytetracycline HCL and dihydrate, flunixin meglumine, meloxicam, cloxacillin benzathine, carprofen, procaine HCL, and benzocaine. The company also has a range of finished products.

This year, CPhI is introducing a new feature—the Innovation Gallery—which aims to highlight innovative development across the pharmaceutical industry. Norbrook will be presenting one of the company’s flagship products, Closamectin Pour-On, which is the only cattle product in Europe that combines ivermectin and closantel for the simultaneous treatment of fluke as well as internal and external parasites.

Source: Norbrook

Related Content:

PharmTech News